Next Article in Journal
Microencapsulation of Essential Oils Using Faba Bean Protein and Chia Seed Polysaccharides via Complex Coacervation Method
Next Article in Special Issue
Effect of the Addition of Inorganic Fillers on the Properties of Degradable Polymeric Blends for Bone Tissue Engineering
Previous Article in Journal
Borane–Trimethylamine Complex: A Versatile Reagent in Organic Synthesis
Previous Article in Special Issue
New Nano-Crystalline Hydroxyapatite-Polycarboxy/Sulfo Betaine Hybrid Materials: Synthesis and Characterization
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Physicochemical Properties of Inorganic and Hybrid Hydroxyapatite-Based Granules Modified with Citric Acid or Polyethylene Glycol

1
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, Poland
2
Solaris National Synchrotron Radiation Centre, Jagiellonian University, Czerwone Maki 98, 30-392 Krakow, Poland
3
Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza Av. 30, 30-058 Krakow, Poland
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(9), 2018; https://doi.org/10.3390/molecules29092018
Submission received: 9 March 2024 / Revised: 7 April 2024 / Accepted: 25 April 2024 / Published: 27 April 2024
(This article belongs to the Special Issue Biomaterials Based on Calcium Phosphates and Their Modifications)

Abstract

:
This study delves into the physicochemical properties of inorganic hydroxyapatite (HAp) and hybrid hydroxyapatite–chitosan (HAp-CTS) granules, also gold-enriched, which can be used as aggregates in biomicroconcrete-type materials. The impact of granules’ surface modifications with citric acid (CA) or polyethylene glycol (PEG) was assessed. Citric acid modification induced increased specific surface area and porosity in inorganic granules, contrasting with reduced parameters in hybrid granules. PEG modification resulted in a slight increase in specific surface area for inorganic granules and a substantial rise for hybrid granules with gold nanoparticles. Varied effects on open porosity were observed based on granule type. Microstructural analysis revealed increased roughness for inorganic granules post CA modification, while hybrid granules exhibited smoother surfaces. Novel biomicroconcretes, based on α-tricalcium phosphate (α-TCP) calcium phosphate cement and developed granules as aggregates within, were evaluated for compressive strength. Compressive strength assessments showcased significant enhancement with PEG modification, emphasizing its positive impact. Citric acid modification demonstrated variable effects, depending on granule composition. The incorporation of gold nanoparticles further enriched the multifaceted approach to enhancing calcium phosphate-based biomaterials for potential biomedical applications. This study demonstrates the pivotal role of surface modifications in tailoring the physicochemical properties of granules, paving the way for advanced biomicroconcretes with improved compressive strength for diverse biomedical applications.

1. Introduction

The search for biocompatible and bioactive materials has led researchers to explore the potential of calcium phosphate cements (CPCs) [1,2]. These remarkable biomaterials have garnered significant interest in recent years due to their unique properties, such as mouldability and setting in situ, diverse applications, and exceptional biocompatibility in various biomedical fields [3]. From bone tissue engineering to dental restoration, CPCs have emerged as a versatile and promising solution for addressing critical challenges in modern healthcare. Extensive research and development have propelled CPCs to the forefront of regenerative medicine, revolutionizing the way we approach bone defects and tissue regeneration.
Their intrinsic similarity to natural bone tissue allows CPCs to mimic the chemical composition of bone and form a bioactive interface with the surrounding biological environment [4]. As a result, CPCs offer not only mechanical support but also actively participate in the tissue healing process, promoting new bone growth and integration.
One of the novel concepts in cementitious materials is biomicroconcretes. They are defined as bone cements containing aggregates in the form of microspheres or granules [5]. The idea of biomicroconcretes was inspired by the construction industry, as it is in concretes that aggregates are found in a cement matrix. The inclusion of granules offers significant advantages, including biocompatibility enhancement by hydroxyapatite or antibacterial activity due to chitosan presence [6]. The incorporation of granules into bone cement compositions has also emerged as a promising strategy to modulate the degradability of bone cements [7] and osteointegration [8]. Previous research has shown that very often in biomicroconcretes there is insufficient adhesion of the granules to the cement matrix, resulting in a deterioration of the mechanical properties of the material [6].
In order to overcome the problems of poor adhesion at the interface between the granules and the cementitious matrix, the idea of using granules in the form of inorganic-organic hybrids (e.g., hydroxyapatite–chitosan [9] or hydroxyapatite–methylcellulose [10]) was developed. It is envisaged that these granules should adhere more effectively through the interaction of the oppositely charged polymer (cationic chitosan) with the calcium phosphate-based cement matrix. To enhance the abovementioned mechanism, the cement matrix itself may contain the oppositely charged polymer [11]. In this way, molecular polyelectrolyte complexes are formed between, for example, the polycationic chitosan present in the granule and the polyanionic polymer in the matrix. Derived from chitin, chitosan is a polysaccharide with excellent biocompatibility and biodegradability [12]. Due to its positive charge, which allows it to interact with negatively charged biomolecules, it has been extensively studied inter alia for drug and gene delivery [13]. Possible interactions can be found, for example, between chitosan and polyanionic pectin [14], alginate [15], or methylcellulose [16].
Another strategy to alter the mechanical properties of biomicroconcretes, such as their compressive strength, is modifying the surface of the granules. This can be performed by various techniques often used for ceramics, for example, acid etching [17,18], plasma treatment [19,20], silanisation [21,22], or pegylation [23,24]/modification with PEG [25].
Across various industrial sectors, citric acid (CA) finds extensive applications, such as food additives, water softeners, and cleaning agents [26]. It is a naturally occurring organic acid found in citrus fruits, making it biodegradable and non-toxic [27]. As a result, its use as a surface modifier or crosslinker [28] is safe for biomedical and biotechnological applications. CA has been utilized in the creation of biodegradable biomaterials for tissue engineering purposes. For instance, a biodegradable poly(diol citrate) polymer has been employed as a scaffold for cartilage tissue engineering and orthopedic fixation devices and as a coating on vascular grafts [29]. Citric acid is recognized for its role in the dissolution of hydroxyapatite tooth enamel, as evidenced by previous studies [30]. Therefore, the interaction between citric acid and HA is of particular interest.
Polyethylene glycol (PEG) is known for its excellent biocompatibility, plasticity, and chemical stability. It is inert and does not elicit a significant immune response. PEGylation, the covalent attachment of PEG chains to biomolecules or surfaces, offers several advantages in various biomedical and industrial applications [31]. PEGylation is a versatile and powerful tool in biotechnology, pharmaceuticals, and materials science. Modification with PEG is a broader term that generally refers to the process of adding PEG to another substance or material.
To the best of our knowledge, there are limited studies focusing on biomicroconcretes. In this study, different types of granules—inorganic hydroxyapatite (HAp), hybrid hydroxyapatite–chitosan (HAp-CTS), and hybrid hydroxyapatite–chitosan modified with gold nanoparticles (Au/HAp-CTS)—have been surface-treated. The modifiers used were citric acid and polyethylene glycol. The chemical and phase composition, specific surface area, open porosity, and microstructure of the granules were characterized. The non-modified, as well as the surface-treated, granules were applied as aggregates in α-TCP-based biomicroconcretes. We hypothesize that the proposed surface treatment will affect the adhesion of granules to the cement matrix and, indirectly, the mechanical properties of the final materials. To analyze the impact of the granules’ modification on biomicroconcrete properties, preliminary studies of the compressive strength of cementitious materials were carried out.

2. Results and Discussion

2.1. Phase Composition

Figure 1 shows diffractograms of inorganic (HAp) and hybrid (HAp-CTS and Au/HAp-CTS) granules. Phase composition studies showed that the granules consisted of hydroxyapatite as the only crystalline phase (see also supplementary materials). Heat-treated granules were highly crystalline, as evidenced by the narrow reflexes; meanwhile, hybrids revealed wide reflexes from non-stoichiometric hydroxyapatite [32]. Additionally, an amorphous halo originating from chitosan in the diffractograms of the hybrid granules could be noticed, similar to the results of other works [33,34]. The modification of the granules with CA or PEG did not alter their phase composition.

2.2. Granules’ Chemical Composition

The FT-IR spectra presented in Figure 2 provide valuable insights into the chemical characteristics of different types of granules, with a focus on their modifications. For pure HAp granules, typical bands for hydroxyapatite were observed [9]. The spectral region spanning from 1100 to 900 cm−1 is attributed to the presence of phosphate groups. The distinct band observed at 958 cm−1 is specifically assigned to the PO43− groups. This assignment is based on the symmetric stretching vibrations of the O-P-O bonds within the tetrahedral geometry of the phosphate group. Further distinctions included the 864 cm−1 band, associated with HPO42− and CO32−, and bands at 600–560 cm−1, also linked to PO43− groups. For the HPO42− ions, this band likely represents the asymmetric stretching vibrations of the P-OH bonds. Meanwhile, in the case of CO32− ions, the same band reflects the asymmetric stretching vibrations of the C-O bonds within the planar trigonal carbonate group. Moreover, bands observed in the range of 600–560 cm−1, also linked to the PO43− groups, correspond to bending vibrations of the O-P-O bonds. The sharp peak at 3569 cm−1 corresponds to the O-H stretching vibration from hydroxyl groups in the crystalline phase. Interestingly, the modification with polyethylene glycol (PEG) or citric acid (CA) did not induce discernible alterations in the spectra. This suggests that the modifiers were effectively washed out during granule preparation, implying a lack of chemical (crosslinking) or physical (hydrogen and electrostatic) interactions between hydroxyapatite and the modifiers (Figure 2a).
In Figure 2b,c, characteristic bands associated with chitosan can be noticed. The hybrid granules display a broad absorption band at 3600–3300 cm−1 due to the stretching vibration of O-H and N-H groups. The bands at 1573 cm−1 and 1407 cm−1 are assigned to N-H bending vibration and C-H bending overlapped with N-H stretching, respectively. The band from the C=O stretching vibration (about 1650–1700 cm−1) was not observed, while the small band at 1266 cm−1 can be assigned to C-N stretching. The HAp-CTS-PEG and Au/HAp-CTS-PEG resultant spectra show that the –NH2 groups of chitosan partially reacted with PEG [35]. This inference was supported by the decrease in the intensity of the peak at 1573 cm−1, suggesting a partial interaction between the free groups of chitosan. In the case of granules modified with citric acid, which possesses a tricarboxylic function group, potential interactions with chitosan were explored. Several interaction types were considered, including amide bonds, ionic interactions, and hydrogen bonds. The absence of a visible, separated peak from the carboxyl group and the overlapping of bands at 1560–1700 cm−1 made it challenging to conclusively assert the occurrence of esterification. For HAp-CTS-CA, Au/HAp-CTS-CA, and Au/HAp-CTS-PEG, a less intense wide band around 3300 cm−1 (O-H and N-H) can suggest hydrogen interaction.

2.3. Specific Surface Area

One of the key characteristics that demonstrates a material’s capacity to interact with its environment is surface area. The specific surface area of the developed granules was determined using the BET method, and the results are presented in Table 1.
The results indicate that modification of inorganic granules led to a slight increase of SSA. The specific surface area of the acid-modified HAp granules was higher (~26 m2/g) compared to their unmodified analogue (~22 m2/g). In the case of HAp granules, citric acid created additional porosity as well as roughness on their surface. For the inorganic PEG-modified granules, a slight increase in specific surface area (~24 m2/g) was observed. It should be pointed out that hybrid granules (HAp-CTS and Au/HAp-CTS) have higher SSA values than HAp granules. It can be concluded that less crystalline hydroxyapatite had a positive impact on surface area. Rydén et al. [36], who were worked on apatitic coatings, noticed a difference between crystalline hydroxyapatite, which revealed a smooth surface, and the amorphous one, which displayed a porous structure, at the nanoscale. In the case of the hybrid granules, modification with CA resulted in a decrease in this parameter—from ~93 to ~75 m2/g for HAp-CTS and from ~82 to ~67 m2/g for Au/HAp-CTS. Citric acid can act as a crosslinking agent [37,38] promoting interactions between hydroxyapatite and chitosan. This could lead to densification or reduced porosity (see Section 2.4), resulting in a decrease in specific surface area. PEG modification can prevent the agglomeration of granules, hindering close contact between particles and reducing their tendency to aggregate [39,40], but PEG molecules may also enter and fill the pores within the hydroxyapatite–chitosan granules, as in the work of Feng et. al. [41], where PEG filled the mesoporous silica. This pore filling can lead to a reduction in the overall porosity of the granules, subsequently decreasing the specific surface. Interestingly, in the case of PEG modification, the specific surface area of the granules with gold nanoparticles significantly increased. Gold nanoparticles in PEG-modified granules might introduce unique surface properties influencing the overall SSA positively.

2.4. Open Porosity

Specific surface area results were consistent with those obtained from mercury porosimetry. The pore size distribution chart is presented in Figure 3. Hydroxyapatite (HAp) granules, both unmodified and subjected to modifications, exhibit distinctive pore size distributions. The unmodified HAp granules display a bimodal distribution, featuring pores in the range of 0.05–0.10 µm and larger gaps between the granules, typically measuring 50–300 µm, as observed in the penetrometer. In the context of HAp-CTS granules, a more intricate trimodal pore size distribution emerges, encompassing ranges of 0.005–0.02 µm, 9–19 µm, and 40–174 µm. The first two ranges are associated with actual pores, with the center range potentially indicative of larger chitosan aggregates that may serve as conduits for substance diffusion or spaces for cellular infiltration [42]. Upon CA modification, the center range in HAp-CTS granules diminishes, and the third range shifts towards higher values, suggesting the possibility of chitosan washout or crosslinking. In the case of PEG-modified HAp-CTS granules, the first range shifts to 0.005–0.03 µm, accompanied by a notable increase in the abundance of those pores. These mesopores, implicated in molecular-level interactions, may play a pivotal role in processes such as adsorption and other surface-related phenomena. For Au/HAp-CTS granules, the pore size distribution mirrors that of PEG-modified HAp-CTS aggregates concerning the first range (0.005–0.02 µm). The second range, 50–300 µm, was low and broad. Upon CA modification of the gold-enriched granules, the first range remains unchanged, while the second range shifts to higher values, mirroring observations in non-Au-containing granules. PEG modification of Au/HAp-CTS granules yields a bimodal distribution akin to HAp-CTS-CA, with ranges of 0.005–0.02 µm and 50–300 µm.
Table 2 summarizes the values for open porosity for developed granules. An increase in porosity from 70 to 75 vol.% was observed for the citric acid-modified inorganic granules, while a decrease in porosity was observed for the hybrid granules. When considering the porosity results for PEG-modified granules, no differences were observed for HAp or HAp-CTS granules. In contrast, an increase in porosity was observed for the PEG-modified hybrid granules, especially those subsidized with gold nanoparticles.
It can be noticed that the result of the CA modification depends largely on the type of granules (inorganic or hybrid). In the case of inorganic granules, the increase in specific surface area and porosity was probably due to the etching of the top layer of ceramic granules [43] and the subsequent opening of some closed pores [44]. In contrast, the decrease in these parameters for the hybrid granules may have been related to the simultaneous dissolution of the chitosan [45] and its crosslinking [46]. Modifications may alter the interactions between chitosan and hydroxyapatite. These changes can influence the overall structure and porosity of the hybrid granules, especially when gold nanoparticles are incorporated.

2.5. Microstructure

The changes in the microstructure of the granules before and after modification are depicted in Figure 4. Upon treatment with citric acid, the inorganic granules exhibited a discernible transformation, manifesting as increased roughness and the formation of grooves on their surface. In the case of PEG-modified HAp granules, no observable differences were discerned when compared to their non-modified counterparts. Intriguingly, the hybrid granules, in contrast, presented a smoother appearance after modification with CA. Notably, the hybrid granules revealed a more prominent visibility of chitosan on their surface—probably due to its crosslinking by citric acid. Similarly, the microstructure of HAp–chitosan granules modified with PEG was smoother, with visible changes. Remarkably, PEG-modified gold-enriched hydroxyapatite–chitosan (Au-HAp–CTS) granules exhibited a pronounced increase in surface roughness compared to their unmodified analogues. This observation aligns with the outcomes of the porosity and specific surface area analyses, indicating a correlation between surface morphology and these key material characteristics.

2.6. Biomicroconcretes’ Compressive Strength

The compressive strength data for biomicroconcretes formulated with the prepared granules are illustrated in Figure 5. In the instance of non-modified granules, the compressive strength values were measured as 3.2 ± 0.8 MPa, 2.1 ± 0.6 MPa, and 3.4 ± 0.8 MPa for B-HAp, B-HAp-CTS, and B-Au/HAp-CTS, respectively. Notably, biomicroconcretes containing unmodified HAp-CTS granules exhibited comparatively lower compressive strength, signifying their inferior mechanical performance. The citric acid modification did not have a noticeable effect on the compressive strength of biomicroconcretes with inorganic HAp granules (3.0 ± 0.7 MPa). On the contrary, for biomicroconcretes incorporating hybrid granules, citric acid modification led to a significant reduction in compressive strength, yielding values of 1.2 ± 0.3 MPa and 2.1 ± 0.6 MPa for B-HAp-CTS*CA and B-Au/HAp-CTS*CA, respectively. The modification of granules with polyethylene glycol (PEG) had an opposite impact on the compressive strength of biomicroconcretes. In each case, PEG modification resulted in a statistically significant increase in compressive strength, yielding values of 3.8 ± 0.5 MPa, 3.7 ± 0.6 MPa, and 4.6 ± 0.4 MPa for B-HAp*PEG, B-HAp-CTS*PEG, and B-Au/HAp-CTS*PEG, respectively. This increase in compressive strength indicates a beneficial effect of PEG modification on the mechanical properties of the biomicroconcretes. Hartatiek et al. [47] demonstrated that a higher concentration of PEG combined with hydroxyapatite results in an increase in density and hardness. The compressive strength values of all biomicroconcretes corresponded to the strength of cancellous bone (0.1–14.0 MPa) [48,49].
The unique combinations of surface treatments applied to different granule types have different effects on the compressive strength of biomicroconcretes. The use of chitosan in hybrid granules leverages their biocompatibility, degradability, and ability to gel under mild conditions (without heat treatment). This facilitates the production of granules through a less energy-consuming process. Concerning other possible benefits of proposed modifications, in the work of Chung et al., it has been shown that the presence of citrate on the surface of hydroxyapatite improves its biocompatibility [50]. Wang et al. claimed that citric acid enhances the physical properties, cytocompatibility, and osteogenesis of magnesium calcium phosphate cement [51]. The second modifier—PEG, according to the literature [52]—efficiently reduces non-specific protein binding and cellular adhesion, enhancing the biocompatibility of biomaterials. As can be seen from the results, gold also plays a very important role. In the work of Shen et al. [53], the PEG-hydroxyapatite-Au nanocomposites exhibited enhanced biological properties and demonstrated superior biocompatibility concerning cell behavior in both MC3T3-E1 cells and MSCs compared to nanocomposites without gold. Moreover, gold nanoparticles have been associated with enhancing bioactivity [54] and antibacterial activity [55]. Further in vitro and in vivo studies are essential to validate the suitability of modified granules for biomedical applications.

3. Materials and Methods

3.1. Materials

In this study, three types of granules—inorganic HAp, hybrid HAp-CTS, and hybrid with gold Au/HAp-CTS (Figure 6)—were developed and modified in two ways. The process of the granules’ preparation is described below.

3.1.1. Inorganic HAp Granules

Hydroxyapatite granules were obtained according to the procedure outlined in Polish Patent No. 154957 [56]. Briefly, the HAp granules were synthesized via wet chemical method using Ca(OH)2 (≥99.5%, Merck, Darmstadt, Germany) and H3PO4 (85.0%, POCH, Gliwice, Poland) as the sources of calcium and phosphorus ions, respectively. The molar Ca:P ratio was equal to 1.67. The obtained suspension underwent a maturation and sedimentation process over two days at room temperature, then was decanted and concentrated by centrifugation to obtain a sediment with approximately 80% moisture content. The resulting filter cake was dried to a constant mass at 90 °C and ground in a mortar to achieve grains below 600 µm. Obtained granules were sintered at 800 °C for 4 h. The thermal treatment significantly contributed to reduced susceptibility to disintegration. For this study, the sintered granules’ fraction of 300–400 µm was used.

3.1.2. Hybrid HAp-CTS Granules

Hybrid hydroxyapatite/chitosan granules (HAp-CTS) were synthesized using a wet chemical method with 17 wt.% of chitosan content. The procedure employed was based on the method described by Zima [9]. In brief, phosphoric acid (Chempur, Piekary Slaskie, Poland) was directly introduced into chitosan solutions in acetic acid (CH3COOH, POCH, Gliwice, Poland), and the resulting mixtures were then added dropwise to a Ca(OH)2 (Merck, Darmstadt, Germany) suspension. For this synthesis, medium molecular weight chitosan was used (approximately 100,000 kDa, with a deacetylation degree of ≥75.0%,), obtained from Sigma-Aldrich, St. Louis, MO, USA. The suspension was left to age for 24 h before being decanted. The resulting precipitate was washed with distilled water, centrifuged, and then frozen for 48 h. Subsequently, after defrosting, the obtained filter cakes were sieved and dried. For this study, the granules’ fraction of 300–400 µm was used.

3.1.3. Hybrid Au-HAp-CTS Granules

The synthesis of gold-modified HAp-CTS granules (AuNPs-HA-CTS) followed a similar wet chemical method and was described previously [5]. The gold nanoparticles were introduced at a concentration of 0.1 wt.% (AuNPs; 99.99% Au, APS-14 nm, obtained from US Research Nanomaterials, Houston, TX, USA) to the hydroxyapatite–chitosan precipitate before the freezing step. Subsequently, upon thawing, granules were obtained.

3.1.4. Modification of the Granules with Citric Acid

To modify the surface of the granules, a 5.0% aqueous solution of citric acid (Chempur, Piekary Slaskie, Poland) was used (Figure 7). After 5 min, the granules were centrifuged and washed four times with distilled water to remove residual acid and dried at 40 °C. The modified granules were named HAp*CA, HAp-CTS*CA, and Au/HAp-CTS*CA.

3.1.5. Modification of the Granules with Polyethylene Glycol

In this case, the 5.0% w/v aqueous polyethylene glycol (average molecular weight of 6000 g/mol, Sigma Aldrich, Poznan, Poland) solution was used to modify the surface of the granules (Figure 8). The unmodified granules were stirred in the solutions for 2 h on a magnetic stirrer. After this step, the granules were filtrated through a cellulose filter and subsequently washed two times with distilled water to remove PEG residues and dried at 40 °C. The PEG-modified granules were named HAp*PEG, HAp-CTS*PEG, and Au/HAp-CTS*PEG.

3.1.6. Granules/Tricalcium Phosphate-Based Biomicroconcretes

To evaluate the impact of the granules’ modification on the compressive strength of biomicroconcretes (B), the set of cementitious samples, in which the matrix consisted of α-tricalcium phosphate (α-TCP) matrix and granules, was prepared. The α-TCP powder was synthesized through a wet chemical method, utilizing high-purity grade Ca(OH)2 (Merck, Dramstadt, Germany) and an 85 wt.% solution of H3PO4 (POCH, Gliwice, Poland) as the substrates. Then the obtained precipitate was subjected to drying, followed by sintering at 1300 °C. The resulting material was then ground using an attritor and sieved to achieve a particle size smaller than 0.063 mm. Biomicroconcretes were prepared by mixing the appropriate granules (300–400 µm) with α-TCP in a mass ratio of 2:3, respectively.
To ensure uniformity in the cementitious composites, a two-step hand-mixing method was applied. In the first step, the solid phase constituents, α-TCP powder and granules, were thoroughly mixed using a spatula for 1 min to achieve a homogeneous distribution. Next, the liquid phase, 0.75% of methylcellulose (Sigma Aldrich, Poznan, Poland) in a 2.0 wt.% solution of Na2HPO4 (Sigma-Aldrich, Hamburg, Germany) was added to the solid phase, and the components were mixed for approximately 30 s until a moldable and hardening paste was obtained. The liquid-to-powder ratio (L/P) for sample preparation was maintained at 0.6 g/g (≈0.5 mL/g). For shaping the samples to the desired form and size, the modulable pastes were introduced into Teflon molds and left to set. Each biomicroconcrete has a “B-“ prefix in its name, followed by the granules used in it.

3.2. Methods

3.2.1. Phase Composition

X-ray diffractometry (XRD) was employed for both qualitative and quantitative identification of phases in the granules. The measurements were conducted on powdered samples, which were previously ground in a mortar and passed through a 0.063 mm mesh sieve. A D2 Phaser diffractometer from Bruker, equipped with a copper lamp and a nickel filter, was utilized for the analysis. The measurements were analyzed in Bragg–Brentano geometry, with an angular range of 2θ from 10° to 40°, using a measuring step of 0.04° and a scanning speed of 2.5° min−1. To determine the granules’ phase compositions, standards from the JCPDS—ICDD (Joint Committee for Powder Diffraction Standards—International Centre for Diffraction Data) database were used.

3.2.2. Specific Surface Area

The specific surface area of the granules was measured using the Brunauer–Emmett–Teller (BET) method with nitrogen gas (ASAP 2000, Micrometric). Before the analysis, the samples were kept in vacuum at 40 °C for 24 h for outgassing to remove the volatile gases. The SSA analyses of the aggregates were conducted to investigate the potential impact of the granules’ modification on this parameter.

3.2.3. Open Porosity

The pore architecture, including open porosity and pore size distribution in the granules, was determined using Mercury Intrusion Porosimetry (MIP). This analysis was conducted with an AutoPore IV 9500 porosimeter from Micromeritics, which is capable of measuring pores ranging from 0.003 to 360 µm in diameter.
To perform the measurements, well-dried granules were introduced into the penetrometer and placed in the low-pressure chamber of the apparatus, where they were de-aerated. Subsequently, mercury was introduced into the penetrometer, and the penetration volume was recorded while increasing the pressure. After conducting the low-pressure measurements, the penetrometer was moved to a high-pressure chamber, where high-pressure measurements were carried out. The analyses were performed twice for each type of granule.

3.2.4. Microstructure

Microstructure observations of the granules were conducted using scanning electron microscopy (SEM, PhenomPure, Thermo Fisher Scientific, Waltham, MA, USA). Before examination, the samples were coated with a thin gold film using a low deposition rate to enhance imaging quality.

3.2.5. FT-IR Analysis

FT-IR measurements were performed using a Bruker Alpha II spectrometer in ATR mode with a diamond crystal. Data acquisition was performed in the 4000−400 cm−1 spectral range, with 4 cm−1 spectral resolution. Samples and background spectra were co-averaged 64 times. The intensities of ATR spectra were corrected using OPUS software (version 8.5). The rubber band correction of the baseline was applied to the spectra.

3.2.6. Compressive Strength Measurements

Cylindrical biomicroconcrete specimens for compressive strength tests were prepared using a mold, ensuring a diameter (d) of 6 ± 1 mm and a height (h) of 12 ± 1 mm. After setting, the samples were removed from the mold and left to dry in the air for 7 days to attain full hardening. The compressive strength was evaluated under dry conditions using an Instron 3345 universal testing machine, with a crosshead speed of 1 mm·min−1. For each material, at least 10 samples were tested. The obtained data were statistically analyzed using one-way analysis of variance (ANOVA) and Tukey’s HSD post hoc multiple comparison test.

4. Conclusions

The study employed three types of granules: inorganic hydroxyapatite (HAp), hybrid hydroxyapatite–chitosan (HAp-CTS), and hybrid hydroxyapatite–chitosan modified with gold nanoparticles (Au/HAp-CTS). Two chemical compounds, namely citric acid and PEG, were utilized to alter the surface properties of the granules. The physicochemical properties of the developed granules were investigated. Also, the impact of modifications on the compressive strength of biomicroconcretes, in which the aforementioned granules constituted aggregates, was assessed.
The results indicated that modification with citric acid led to an increase in the specific surface area and porosity of inorganic granules, while it reduced these parameters for hybrid granules. PEG modification showed a slight increase in the specific surface area of inorganic granules and a significant increase for hybrid granules with gold nanoparticles. Open porosity results revealed a decrease for the hybrid granules, probably due to the simultaneous dissolution and crosslinking of the chitosan. Analysis of microstructure changes post-modification indicated increased surface roughness for inorganic granules after modification with citric acid, while hybrid granules exhibited smoother surfaces with visible changes. Compressive strength tests on biomicroconcretes demonstrated that PEG modification significantly increased compressive strength, while citric acid modification had variable effects depending on the type of granules. It did not have an impact on the inorganic HAp granules but was detrimental for hybrids (HAp-CTS and Au/HAp-CTS).
The findings suggest that surface modifications influence the physicochemical properties of granules. The combination of surface modification and the incorporation of gold nanoparticles presents a multifaceted approach to enhancing the properties of calcium phosphate-based biomaterials. The results provide insights into potential applications of modified granules in biomedical fields, emphasizing the importance of further in vitro and in vivo studies to validate their suitability for specific biomedical applications.
We can conclude that different types of granules can be used as aggregates in biomicroconcrete-type materials. In turn, the modification of granules can lead to the change of biomicroconcrete properties such as improved compressive strength.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29092018/s1.

Author Contributions

Conceptualization, E.C.; Methodology, E.C., K.K. and A.Z.; Validation, J.P.C.; Investigation, E.C., K.K. and P.P.; Resources, J.P.C. and A.Z.; Data curation, E.C. and K.K.; Writing—original draft, E.C.; Writing—review & editing, K.K., P.P., J.P.C., A.Z. and A.Ś.; Visualization, E.C. and K.K.; Supervision, A.Ś.; Funding acquisition, A.Ś. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Science Centre, Poland Grant No. 2017/27/B/ST8/01173. The research was partially supported by the programme “Excellence initiative—research university” for the AGH University of Krakow and the AGH Faculty of Materials Science and Ceramics (Project No. 16.16.160.557).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Acknowledgments

The authors would like to thank Kamil Kornaus for the measurements of SSA and Dawid Kozień for help with the Rietveld analysis. This publication was partially developed under the provision of the Polish Ministry and Higher Education project “Support for research and development with the use of research infrastructure of the National Synchrotron Radiation Centre SOLARIS” under contract no. 1/SOL/2021/2. We acknowledge the SOLARIS Centre for the access to the Beamline CIRI where the FT-IR measurements were performed.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. We, B. A new calcium phosphate water setting cement. Cem. Res. Prog. 1986, 352–379. [Google Scholar]
  2. Takeyama, H.; Maruta, M.; Sato, T.; Kajimoto, N.; Fujii, E.; Matsuura, T.; Tsuru, K. Fabrication of bioresorbable hydroxyapatite bone grafts through the setting reaction of calcium phosphate cement. Dent. Mater. J. 2022, 41, 882–888. [Google Scholar] [CrossRef] [PubMed]
  3. Eliaz, N.; Metoki, N. Calcium phosphate bioceramics: A review of their history, structure, properties, coating technologies and biomedical applications. Materials 2017, 10, 334. [Google Scholar] [CrossRef] [PubMed]
  4. Schröter, L.; Kaiser, F.; Stein, S.; Gbureck, U.; Ignatius, A. Biological and mechanical performance and degradation characteristics of calcium phosphate cements in large animals and humans. Acta Biomater. 2020, 117, 1–20. [Google Scholar] [CrossRef] [PubMed]
  5. Czechowska, J.; Cichoń, E.; Belcarz, A.; Ślósarczyk, A.; Zima, A. Effect of gold nanoparticles and silicon on the bioactivity and antibacterial properties of hydroxyapatite/chitosan/tricalcium phosphate-based biomicroconcretes. Materials 2021, 14, 3854. [Google Scholar] [CrossRef] [PubMed]
  6. Ślósarczyk, A.; Czechowska, J.; Cichoń, E.; Zima, A. New hybrid bioactive composites for bone substitution. Processes 2020, 8, 335. [Google Scholar] [CrossRef]
  7. Sarkar, S.K.; Lee, B.Y.; Padalhin, A.R.; Sarker, A.; Carpena, N.; Kim, B.; Paul, K.; Choi, H.J.; Bae, S.H.; Lee, B.T. Brushite-based calcium phosphate cement with multichannel hydroxyapatite granule loading for improved bone regeneration. J. Biomater. Appl. 2016, 30, 823–837. [Google Scholar] [CrossRef] [PubMed]
  8. Fuchs, A.; Kreczy, D.; Brückner, T.; Gbureck, U.; Stahlhut, P.; Bengel, M.; Hoess, A.; Nies, B.; Bator, J.; Klammert, U.; et al. Bone regeneration capacity of newly developed spherical magnesium phosphate cement granules. Clin. Oral Investig. 2021, 1–15. [Google Scholar] [CrossRef] [PubMed]
  9. Zima, A. Hydroxyapatite-chitosan based bioactive hybrid biomaterials with improved mechanical strength. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2018, 193, 175–184. [Google Scholar] [CrossRef]
  10. Czechowska, J. Self-assembling, hybrid hydroxyapatite-methylcellulose granules, modified with nano-silver. Mater. Lett. 2021, 300, 130156. [Google Scholar] [CrossRef]
  11. Dziadek, M.; Zima, A.; Cichoń, E.; Czechowska, J.; Ślósarczyk, A. Biomicroconcretes based on the hybrid HAp/CTS granules, α-TCP and pectins as a novel injectable bone substitutes. Mater. Lett. 2020, 265, 127457. [Google Scholar] [CrossRef]
  12. Martău, G.A.; Mihai, M.; Vodnar, D.C. The use of chitosan, alginate, and pectin in the biomedical and food sector—Biocompatibility, bioadhesiveness, and biodegradability. Polymers 2019, 11, 1837. [Google Scholar] [CrossRef] [PubMed]
  13. Garg, U.; Chauhan, S.; Nagaich, U.; Jain, N. Current advances in chitosan nanoparticles based drug delivery and targeting. Adv. Pharm. Bull. 2019, 9, 195. [Google Scholar] [CrossRef] [PubMed]
  14. Pańtak, P.; Cichoń, E.; Czechowska, J.; Zima, A. Influence of natural polysaccharides on properties of the biomicroconcrete-type bioceramics. Materials 2021, 14, 7496. [Google Scholar] [CrossRef] [PubMed]
  15. Lee, H.J.; Kim, B.; Padalhin, A.R.; Lee, B.T. Incorporation of chitosan-alginate complex into injectable calcium phosphate cement system as a bone graft material. Mater. Sci. Eng. C 2019, 94, 385–392. [Google Scholar] [CrossRef] [PubMed]
  16. Czechowska, J.; Zima, A.; Ślósarczyk, A. Comparative study on physicochemical properties of alpha-TCP/calcium sulphate dihydrate biomicroconcretes containing chitosan, sodium alginate or methylcellulose. Acta Bioeng. Biomech. 2020, 22, 47–56. [Google Scholar] [CrossRef] [PubMed]
  17. Skibiński, S.; Czechowska, J.P.; Cichoń, E.; Seta, M.; Gondek, A.; Cudnoch-Jędrzejewska, A.; Zima, A. Study on βTCP/P (3HB) Scaffolds—Physicochemical Properties and Biological Performance in Low Oxygen Concentration. Int. J. Mol. Sci. 2022, 23, 11587. [Google Scholar] [CrossRef] [PubMed]
  18. Nakonieczny, D.S.; Slíva, A.; Paszenda, Z.; Hundáková, M.; Kratošová, G.; Holešová, S.; Simha Martynková, G. Simple approach to medical grade alumina and zirconia ceramics surface alteration via acid etching treatment. Crystals 2021, 11, 1232. [Google Scholar] [CrossRef]
  19. Kazimierczak, P.; Przekora, A. Osteoconductive and osteoinductive surface modifications of biomaterials for bone regeneration: A concise review. Coatings 2020, 10, 971. [Google Scholar] [CrossRef]
  20. Kowalczyk, P.; Wojasiński, M.; Jaroszewicz, J.; Kopeć, K.; Ciach, T. Controlled formation of highly porous polylactic acid-calcium phosphate granules with defined structure. Biomater. Adv. 2023, 144, 213195. [Google Scholar] [CrossRef] [PubMed]
  21. Siniscalco, D.; Dutreilh-Colas, M.; Hjezi, Z.; Cornette, J.; El Felss, N.; Champion, E.; Damia, C. Functionalization of hydroxyapatite ceramics: Raman mapping investigation of silanization. Ceramics 2019, 2, 372–384. [Google Scholar] [CrossRef]
  22. Aneb, K.; Oudadesse, H.; Khireddine, H.; Lefeuvre, B.; Merdrignac-Conanec, O.; Tessier, F.; Lucas, A. Study of the effect of ordered porosity and surface silanization on in vitro bioactivity of sol-gel-derived bioactive glasses. Mater. Today Commun. 2023, 34, 104992. [Google Scholar] [CrossRef]
  23. de los Ángeles Ramírez, M.; Bindini, E.; Moretti, P.; Illia, G.J.S.; Amenitsch, H.; Andreozzi, P.; Moya, S.E. Impact of PEGylation on the degradation and pore organization in mesoporous silica nanoparticles: A study of the inner mesoporous structure in physiologically relevant ionic conditions. Colloids Surf. B Biointerfaces 2022, 219, 112797. [Google Scholar]
  24. Ali, M.; Mujtaba-ul-Hassan, S.; Ahmad, J.; Khurshid, A.; Shahzad, F.; Iqbal, Z.; Waheed, K. Fabrication of PEGylated Porous Alumina Whiskers (PAW) for drug delivery applications. Mater. Lett. 2019, 241, 23–26. [Google Scholar] [CrossRef]
  25. Kumar, P.; Saini, M.; Kumar, V.; Dehiya, B.S.; Sindhu, A.; Fouad, H.; Ahmad, N.; Mahmood, A.; Hashem, M. Polyethylene glycol (PEG) modified porous Ca5 (PO4) 2SiO4 bioceramics: Struc-tural, morphologic and bioactivity analysis. Coatings 2020, 10, 538. [Google Scholar] [CrossRef]
  26. Gyawali, D.; Nair, P.; Zhang, Y.; Tran, R.T.; Zhang, C.; Samchukov, M.; Yang, J. Citric acid-derived in situ crosslinkable biodegradable polymers for cell delivery. Biomaterials 2010, 31, 9092–9105. [Google Scholar] [CrossRef]
  27. Reena, R.; Sindhu, R.; Balakumaran, P.A.; Pandey, A.; Awasthi, M.K.; Binod, P. Insight into citric acid: A versatile organic acid. Fuel 2022, 327, 125181. [Google Scholar] [CrossRef]
  28. Salihu, R.; Abd Razak, S.I.; Zawawi, N.A.; Kadir, M.R.A.; Ismail, N.I.; Jusoh, N.; Nayan, N.H.M. Citric acid: A green cross-linker of biomaterials for biomedical applications. Eur. Polym. J. 2021, 146, 110271. [Google Scholar] [CrossRef]
  29. Tran, R.T.; Yang, J.; Ameer, G.A. Citrate-based biomaterials and their applications in regenerative engineering. Annu. Rev. Mater. Res. 2015, 45, 277–310. [Google Scholar] [CrossRef] [PubMed]
  30. Barbour, M.E.; Parker, D.M.; Allen, G.C.; Jandt, K.D. Enamel dissolution in citric acid as a function of calcium and phosphate concentrations and degree of saturation with respect to hydroxyapatite. Eur. J. Oral Sci. 2003, 111, 428–433. [Google Scholar] [CrossRef] [PubMed]
  31. Ibrahim, M.; Ramadan, E.; Elsadek, N.E.; Emam, S.E.; Shimizu, T.; Ando, H.; Ishida, T. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products. J. Control. Release 2022, 351, 215–230. [Google Scholar] [CrossRef]
  32. Assis, C.M.D.; Vercik, L.C.D.O.; Santos, M.L.D.; Fook, M.V.L.; Guastaldi, A.C. Comparison of crystallinity between natural hydroxyapatite and synthetic cp-Ti/HA coatings. Mater. Res. 2005, 8, 207–211. [Google Scholar] [CrossRef]
  33. Panda, P.K.; Yang, J.M.; Chang, Y.H.; Su, W.W. Modification of different molecular weights of chitosan by p-Coumaric acid: Preparation, characterization and effect of molecular weight on its water solubility and antioxidant property. Int. J. Biol. Macromol. 2019, 136, 661–667. [Google Scholar] [CrossRef] [PubMed]
  34. Pashameah, R.A.; Ibrahium, H.A.; Awwad, N.S.; Farea, M.O.; Ahmed, H.A.; El-Morsy, M.A.; Menazea, A.A. Modification and development of the optical, structural, thermal and electrical characterization of Chitosan incorporated with Au/Bi2O3/Mo NPs fabricated by laser ablation. J. Inorg. Organomet. Polym. Mater. 2022, 32, 2729–2736. [Google Scholar] [CrossRef]
  35. Vijayan, A.A.S.; Kumar, G.S.V. PEG grafted chitosan scaffold for dual growth factor delivery for enhanced wound healing. Sci. Rep. 2019, 9, 19165. [Google Scholar] [CrossRef] [PubMed]
  36. Rydén, L.; Omar, O.; Johansson, A.; Jimbo, R.; Palmquist, A.; Thomsen, P. Inflammatory cell response to ultra-thin amorphous and crystalline hydroxyapatite surfaces. J. Mater. Sci. Mater. Med. 2017, 28, 9. [Google Scholar] [CrossRef]
  37. Gawish, S.M.; Abo El-Ola, S.M.; Ramadan, A.M.; Abou El-Kheir, A.A. Citric acid used as a crosslinking agent for the grafting of chitosan onto woolen fabric. J. Appl. Polym. Sci. 2012, 123, 3345–3353. [Google Scholar] [CrossRef]
  38. Khouri, J. Chitosan Edible Films Crosslinked by Citric Acid. 2019. Available online: http://hdl.handle.net/10012/14877 (accessed on 1 July 2023).
  39. Lazaro-Carrillo, A.; Filice, M.; Guillén, M.J.; Amaro, R.; Viñambres, M.; Tabero, A.; Marciello, M. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers. Mater. Sci. Eng. C 2020, 107, 110262. [Google Scholar] [CrossRef] [PubMed]
  40. Jegatheeswaran, S.; Sundrarajan, M. PEGylation of novel hydroxyapatite/PEG/Ag nanocomposite particles to improve its antibacterial efficacy. Mater. Sci. Eng. C 2015, 51, 174–181. [Google Scholar] [CrossRef] [PubMed]
  41. Feng, D.; Feng, Y.; Li, P.; Zang, Y.; Wang, C.; Zhang, X. Modified mesoporous silica filled with PEG as a shape-stabilized phase change materials for improved thermal energy storage performance. Microporous Mesoporous Mater. 2020, 292, 109756. [Google Scholar] [CrossRef]
  42. Vallet-Regí, M.; Balas, F.; Arcos, D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 2007, 46, 7548–7558. [Google Scholar] [CrossRef] [PubMed]
  43. Misra, D.N. Interaction of citric acid with hydroxyapatite: Surface exchange of ions and precipitation of calcium citrate. J. Dent. Res. 1996, 75, 1418–1425. [Google Scholar] [CrossRef] [PubMed]
  44. Li, S.H.; de Wijn, J.R.; Layrolle, P.; de Groot, K. Novel method to manufacture porous hydroxyapatite by dual-phase mixing. J. Am. Ceram. Soc. 2003, 86, 65–72. [Google Scholar] [CrossRef]
  45. Bégin, A.; Van Calsteren, M.R. Antimicrobial films produced from chitosan. Int. J. Biol. Macromol. 1999, 26, 63–67. [Google Scholar] [CrossRef] [PubMed]
  46. Khouri, J.; Penlidis, A.; Moresoli, C. Viscoelastic properties of crosslinked chitosan films. Processes 2019, 7, 157. [Google Scholar] [CrossRef]
  47. Utomo, J.; Noerjannah, L.I.; Rohmah, N.Z. Physical and mechanical properties of hydroxyapatite/polyethylene glycol nanocomposites. Mater. Today Proc. 2021, 44, 3263–3267. [Google Scholar]
  48. Nazarian, A.; Von Stechow, D.; Zurakowski, D.; Müller, R.; Snyder, B.D. Bone volume fraction explains the variation in strength and stiffness of cancellous bone affected by metastatic cancer and osteoporosis. Calcif. Tissue Int. 2008, 83, 368–379. [Google Scholar] [CrossRef]
  49. Kopperdahl, D.L.; Keaveny, T.M. Yield strain behavior of trabecular bone. J. Biomech. 1998, 31, 601–608. [Google Scholar] [CrossRef] [PubMed]
  50. Chung, E.J.; Sugimoto, M.J.; Ameer, G.A. The role of hydroxyapatite in citric acid-based nanocomposites: Surface characteristics, degradation, and osteogenicity in vitro. Acta Biomater. 2011, 7, 4057–4063. [Google Scholar] [CrossRef] [PubMed]
  51. Wang, S.; Xu, C.; Yu, S.; Wu, X.; Jie, Z.; Dai, H. Citric acid enhances the physical properties, cytocompatibility and osteogenesis of magnesium calcium phosphate cement. J. Mech. Behav. Biomed. Mater. 2019, 94, 42–50. [Google Scholar] [CrossRef] [PubMed]
  52. Rhodes, A.; Sandhu, S.S.; Onis, S.J. Surface modification of biomaterials by covalent binding of poly (ethylene glycol)(PEG). Surf. Modif. Biomater. 2011, 39–55. [Google Scholar] [CrossRef]
  53. Shen, C.C.; Hsu, S.H.; Chang, K.B.; Yeh, C.A.; Chang, H.C.; Tang, C.M.; Hung, H.S. Physical gold nanoparticle-decorated polyethylene glycol-hydroxyapatite composites guide osteogenesis and angiogenesis of mesenchymal stem cells. Biomedicines 2021, 9, 1632. [Google Scholar] [CrossRef] [PubMed]
  54. Anwar, A.; Siddiqui, R.; Shah, M.; Khan, N. Gold nanoparticles conjugation enhances antiacanthamoebic properties of nystatin, fluconazole, and amphotericin B. J. Microbiol. Biotechnol. 2019, 29, 171–177. [Google Scholar] [CrossRef] [PubMed]
  55. Gu, X.; Xu, Z.; Gu, L.; Xu, H.; Han, F.; Chen, B.; Pan, X. Preparation and anti-bacterial properties of gold nanoparticles: A review. Environ. Chem. Lett. 2021, 19, 167–187. [Google Scholar]
  56. Ślósarczyk, A. Ceramic Implantation Material and the Method of Obtaining of Ceramic Implantation Material. Polish patent PL154957B1, 18 April 1988. [Google Scholar]
Figure 1. Diffractograms of initial granules. The main reflex for chitosan is marked with a gold dot.
Figure 1. Diffractograms of initial granules. The main reflex for chitosan is marked with a gold dot.
Molecules 29 02018 g001
Figure 2. FT-IR of three types of granules: (a) without CTS modification, (b) granules modified with CTS, (c) granules additionally modified with Au.
Figure 2. FT-IR of three types of granules: (a) without CTS modification, (b) granules modified with CTS, (c) granules additionally modified with Au.
Molecules 29 02018 g002
Figure 3. Pore size distribution graphs for the developed granules.
Figure 3. Pore size distribution graphs for the developed granules.
Molecules 29 02018 g003
Figure 4. Microstructure of the obtained granules (scale bar: 300 µm).
Figure 4. Microstructure of the obtained granules (scale bar: 300 µm).
Molecules 29 02018 g004
Figure 5. Compressive strength of the developed biomicroconcretes (significance bars meaning—black: not significant, blue: p < 0.1, orange: p < 0.05, without any bar: p < 0.01).
Figure 5. Compressive strength of the developed biomicroconcretes (significance bars meaning—black: not significant, blue: p < 0.1, orange: p < 0.05, without any bar: p < 0.01).
Molecules 29 02018 g005
Figure 6. Morphology of the unmodified granules (SEM magnification: 500×, scale bars that correspond to a length of 100 µm are present on each SEM image in the lower left corner, depicted in white).
Figure 6. Morphology of the unmodified granules (SEM magnification: 500×, scale bars that correspond to a length of 100 µm are present on each SEM image in the lower left corner, depicted in white).
Molecules 29 02018 g006
Figure 7. Scheme of modification of granules with citric acid.
Figure 7. Scheme of modification of granules with citric acid.
Molecules 29 02018 g007
Figure 8. Modification procedure of granules with polyethylene glycol.
Figure 8. Modification procedure of granules with polyethylene glycol.
Molecules 29 02018 g008
Table 1. Specific surface area of obtained granules.
Table 1. Specific surface area of obtained granules.
Specific Surface Area [m2/g]
GranulesHApHAp-CTSAu/HAp-CTS
Non-modified 22.36 ± 0.0293.48 ± 0.2682.41 ± 0.18
CA-modified26.32 ± 0.0574.54 ± 0.1366.94 ± 0.11
PEG-modified23.99 ± 0.0579.51 ± 0.17111.10 ± 0.21
Table 2. Open porosity of the obtained granules.
Table 2. Open porosity of the obtained granules.
Porosity [vol.%]Material
HAp HAp-CTS Au/HAp-CTS
Non-modified70 ± 268 ± 163 ± 2
CA-modified75 ± 163 ± 257 ± 3
PEG-modified68 ± 370 ± 270 ± 1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cichoń, E.; Kosowska, K.; Pańtak, P.; Czechowska, J.P.; Zima, A.; Ślósarczyk, A. Physicochemical Properties of Inorganic and Hybrid Hydroxyapatite-Based Granules Modified with Citric Acid or Polyethylene Glycol. Molecules 2024, 29, 2018. https://doi.org/10.3390/molecules29092018

AMA Style

Cichoń E, Kosowska K, Pańtak P, Czechowska JP, Zima A, Ślósarczyk A. Physicochemical Properties of Inorganic and Hybrid Hydroxyapatite-Based Granules Modified with Citric Acid or Polyethylene Glycol. Molecules. 2024; 29(9):2018. https://doi.org/10.3390/molecules29092018

Chicago/Turabian Style

Cichoń, Ewelina, Karolina Kosowska, Piotr Pańtak, Joanna P. Czechowska, Aneta Zima, and Anna Ślósarczyk. 2024. "Physicochemical Properties of Inorganic and Hybrid Hydroxyapatite-Based Granules Modified with Citric Acid or Polyethylene Glycol" Molecules 29, no. 9: 2018. https://doi.org/10.3390/molecules29092018

APA Style

Cichoń, E., Kosowska, K., Pańtak, P., Czechowska, J. P., Zima, A., & Ślósarczyk, A. (2024). Physicochemical Properties of Inorganic and Hybrid Hydroxyapatite-Based Granules Modified with Citric Acid or Polyethylene Glycol. Molecules, 29(9), 2018. https://doi.org/10.3390/molecules29092018

Article Metrics

Back to TopTop